OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Depression and cardiovascular risk—association among Beck Depression Inventory, PCSK9 levels and insulin resistance
C. Macchi, C. Favero, Alessandro Ceresa, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 40

Showing 26-50 of 40 citing articles:

The Impact of the Triglyceride-Glucose Index on the Development of Depression in Patients with Coronary Atherosclerotic Heart Disease
Jing Guan, Y.L. Wang, Changjun Dong, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 2105-2113
Open Access | Times Cited: 1

Pharmaceutical management of sexual dysfunction in men on antidepressant therapy
Ahmed M. Bakr, Amro A. El‐Sakka, Ahmed I. El‐Sakka
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 9, pp. 1051-1063
Closed Access | Times Cited: 7

Impact of mental disorders on the risk of atrial fibrillation in patients with diabetes mellitus: a nationwide population-based study
Nan Young Bae, So‐Ryoung Lee, Eue‐Keun Choi, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 6

Effects of a group-based weight management programme on anxiety and depression: A randomised controlled trial (RCT)
Laura Heath, Susan A. Jebb, Richard Stevens, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0263228-e0263228
Open Access | Times Cited: 5

Function of proprotein convertase subtilisin/kexin type 9 and its role in central nervous system diseases: An update on clinical evidence
Xiaobin Zhu, Y.-M. Xu, Liucheng Li, et al.
Drug Development Research (2023) Vol. 85, Iss. 1
Closed Access | Times Cited: 2

Plasma nontargeted peptidomics discovers potential biomarkers for major depressive disorder
Yi Wang, Xinxin Liu, Dan Liu, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2021) Vol. 15, Iss. 6
Closed Access | Times Cited: 5

Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study
Sandra Martín‐Peláez, Lluís Serra‐Majem, Naomi Cano‐Ibáñez, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0265079-e0265079
Open Access | Times Cited: 3

Plasminogen Activator Inhibitor‐1 in the Pathophysiology of Late Life Depression
Lucie Métivier, Denis Vivien, R. Goy, et al.
International Journal of Geriatric Psychiatry (2024) Vol. 39, Iss. 11
Closed Access

Study of glucose homeostasis in burnout cases using an oral glucose tolerance test
Anna-Karin Lennartsson, Ingibjörg H. Jónsdóttir, Per‐Anders Jansson, et al.
Stress (2024) Vol. 28, Iss. 1
Open Access

Sex-Specific Association of Endogenous PCSK9 With Memory Function in Elderly Subjects at High Cardiovascular Risk
Paola Simeone, Francesco Vadini, Romina Tripaldi, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 2

Happiness is related to cardiovascular risk: a cross-sectional study in Spain
Oriol Yuguero, Ana Blasco‐Belled, Álvaro Vilela, et al.
Psychology Health & Medicine (2021) Vol. 27, Iss. 3, pp. 715-721
Closed Access | Times Cited: 2

Previous Page - Page 2

Scroll to top